SHENZHEN Hemogen Therapeutic Co., Ltd.

On October 16th, during the visit of Indonesian President Joko Widodo to China and his attendance at the third Belt and Road International Cooperation...

Upon the invitation of KALBE, Indonesia's largest pharmaceutical company, and innovative biopharmaceutical company Etana Biotechnologies, Dr. Chao...

On October 10, 2023, CG Therapeutics Private Limited (CGT) and Hemogen HongKong Alpha Technology Limited, a subsidiary of Hemogen (Hong Kong), officia...

On July 18th, Dr. Chao Liu, CEO of Hemogen, Mr. Preecha Laohapongchana, Director of Xingtai Genetics, Dr. Apichat Asavamongkolkul, Dean of the Faculty...

May 8, 2023 marks the 30th World Thalassemia Day. In order to further improve the prevention and treatment of Mediterranean anemia (hereinafter referr...

On February 10, 2023, Hemogen Theropeutic Co.Ltd (Hemogen, a subsidiary of BGI), Thalassemia Diagnosis and Treatment Innovation Research Center of Nan...

The Middle East and Southeast Asia are high-prevalence areas for thalassemia and sickle cell anemia as well as significant regions along Belt and Road...

Shenzhen Hemogen Therapeutics Co., Ltd. (hereinafter referred to as: HGI) cooperated with department of hematology of 923 Hospital on the topic of “Cl...